SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 2, 2017
MEDICAL INNOVATION HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
or Other Jurisdiction
5805 State Bridge Road, Suite G-328, Duluth, Georgia 30097
(Address of Principal Executive Offices) (Zip Code)
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|[ ]||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|[ ]||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|[ ]||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|[ ]||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
SECTION 7 — REGULATION FD DISCLOSURE
Item 7.01 Regulation FD Disclosure .
The information in this Item 7.01 of this Current Report is furnished pursuant to Item 7.01 and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing
under the Securities Act or the Exchange Act regardless of any general incorporation language
in such filing.
On November 2, 2017 Medical Innovation Holdings Inc. issued a press release.
The text of the press release in its entirety is attached herewith as Exhibit 99.1.
SECTION 9 — FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statements and Exhibits.
The following is a complete list of exhibits filed as part of this Report.
Exhibit numbers correspond to the numbers in the exhibit table of Item 601 of Regulation S-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|Medical Innovation Holdings, Inc.|
|By:||/s/ Arturo Jake Sanchez|
Name: Arturo “Jake” Sanchez
Date: November 3, 2017
Medical Innovation Holdings, Inc (MIHI) Announces the Build out of a National Tele-Medicine Network to Support President Trump’s declaration of War on Addiction
President Trump declares the Opioid Crisis Across America a National Public Health Emergency triggering The Public Health Service Act. Telemedicine Coverage Seen as a Solution.
DULUTH, GEORGIA – 11/02/2017
Medical Innovation Holdings, Inc, announces an acceleration of deploying a national tele-medicine infrastructure with virtual addiction specialist to work with the thousands of Americans addicted to pain killers in all areas of the country with a focus on rural and remote areas of the country.
Having the President declare a National Public Health Emergency will provide federal health officials the ability to circumvent many existing policies regarding public health allowing for a national network to exist.
Jake Sanchez, CEO, explains “that under the act Dr. Don Wright, Secretary of Health and Human Services, will be able to modify the practice of telemedicine. In other words, using telemedicine to treat addiction and prescribe medication for Medicare, Medicaid, and Children’s Health and Insurance Program, known as CHIPS. We are uniquely positioned to answer this call to duty”.
According to the National Institute on Drug Abuse there were 20,000 deaths in 2016 attributed to fentanyl and fentanyl analogs (synthetic opioids) with a total of 64,000 deaths due to overdoses in the USA. It is no wonder the President has declared it a national emergency. (https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates)
Sanchez goes on to say “the government may also relax the licensor laws allowing doctors from any state to treat any patient. This could be a game changer in the use of telemedicine to solve national epidemics. The network can be deployed quickly because the communication infrastructure in many parts of the country is already in place. (In USA 99.73% of the population has access to Broadband Internet https://geoisp.com/us/ ) Our cloud-based software to provide the necessary medical information and records has been completed and is being tested. Aggregating abuse and addiction specialist can be easily accomplished by suspending the licensor laws.
About Medical Innovation Holdings, Inc.
MIHI, a Colorado-based publicly traded company, owns and operates strategically aligned health care service companies focused on the delivery of clinical virtual medicine (health) as a way of bringing quality medical care to all areas of need including rural and underdeveloped areas across the country. Through our wholly owned subsidiary, 3Point Care, we provide personalized high-tech high-touch telemedicine encounters pairing our virtual health specialty doctors with traditional primary doctors utilizing nextgen virtual health technologies in order to connect a patient with a multi-disciplinary specialty clinical healthcare practice. Through our other companies and relationships, we offer Affordable Care Organization (ACO) support, wellness and prevention, lab analysis and lab services, and remote diagnostic monitoring.
We serve a number of constituents and stakeholders interested in reducing the cost of care, enhancing the quality of care, promoting access to care, and maintaining the continuum of care.
For more information on MIHI please visit the Company’s website at http://www.medicalinnovationholdings.com
To leave a message please call +1-866-883-3793 for Investor Relations
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov .